Today's News |
|
Burnaby-based Xenon Pharmaceuticals Shares Soar on Strong Results for Epilepsy Drug, Company Becomes Latest BC Tech Unicorn
Tuesday, October 5, 2021
Vancouver, BC, October 5, 2021--Shares in drug developer Xenon Pharmaceuticals more than doubled on Monday after the Vancouver company published strong efficacy results for its epilepsy drug, making it the latest in a string of domestic biotechnology companies to surpass the US$1-billion valuation mark. Xenon shares surged 101.9 per cent to close at US$31.50 on the Nasdaq stock market, giving the company a market capitalization of nearly $1.3-billion.
|
Share |
|||
|
Member Toolbar |
Globe and Mail Posted: Oct 5, 2021 |
News Actions |
Navigation |
Hiring Today |
|||||||||||||||||||
See All Jobs |
|||||||||||||||||||
Copyright © T-NET. All Rights Reserved. | https://www.bctechnology.com |
|